A5056914151- Asthma and respiratory diseases
- Inhalation and Respiratory Drug Delivery
- Allergic Rhinitis and Sensitization
- Obstructive Sleep Apnea Research
- Respiratory and Cough-Related Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Renal Diseases and Glomerulopathies
- Neuroscience of respiration and sleep
- Atrial Fibrillation Management and Outcomes
- Neonatal Respiratory Health Research
- Cardiac Arrhythmias and Treatments
- Antibiotics Pharmacokinetics and Efficacy
- Cardiac electrophysiology and arrhythmias
- Pharmaceutical studies and practices
- Food Allergy and Anaphylaxis Research
- Tracheal and airway disorders
- Pediatric health and respiratory diseases
- Drug-Induced Adverse Reactions
- Diabetes Management and Research
- Biosimilars and Bioanalytical Methods
- Antifungal resistance and susceptibility
- Genetic Syndromes and Imprinting
- Nutrition and Health in Aging
- Pharmacovigilance and Adverse Drug Reactions
- Amyloidosis: Diagnosis, Treatment, Outcomes
National and Kapodistrian University of Athens
2016-2025
Panagiotis & Aglaia Kyriakou Children's Hospital
2023-2024
Children's Hospital Agia Sophia
2014-2021
University of Thessaly
2010-2021
Iaso Children’s Hospital
2019-2021
Ibero American University
2016
Tufts University
2013-2015
Tufts Medical Center
2015
Brown University
2015
ABSTRACT Background G209A SNCA mutation carriers represent an important group of genetic PD. We describe motor and nonmotor features carriers. Methods Longitudinal clinical assessments over 2 years were collected in 22 symptomatic 8 asymptomatic Motor rating scales administered. Correlations performed between variables disease duration or age. Penetrance was calculated using Kaplan‐Meier survival curves. Results Asymptomatic did not manifest clear premotor symptoms, but often reported that...
Abstract Wheezing is the cardinal symptom of asthma; its presence early in life, mostly caused by viral infections, a major risk factor for establishment persistent or recurrent disease. Early‐life wheezing and asthma exacerbations are triggered common respiratory viruses, mainly rhinoviruses (RV), to lesser extent, syncytial virus, parainfluenza, human metapneumovirus, coronaviruses, adenoviruses, influenza, bocavirus. The excess bacteria, several which part microbiome, has also been...
Respiratory allergic diseases, affect over 500 million people globally and pose a substantial burden in terms of morbidity, mortality, healthcare costs. Restrictive factors such as geographical disparities, infectious pandemics, limitations resource, shortage allergy specialists underserved areas, impede effective management. Moreover, the well-established suboptimal adherence patients with respiratory allergies, contribute further to accelerated loss disease control.
 Telemedicine...
Respiratory allergic diseases affect over 500 million people globally and pose a substantial burden in terms of morbidity, mortality, healthcare costs. Restrictive factors such as geographical disparities, infectious pandemics, limitations resources, shortages allergy specialists underserved areas impede effective management. Telemedicine encompasses real-time visits, store-and-forward option triage, computer-based technologies for establishing efficient doctor-patient communication. Recent...